Volume Alert - SLXP 91.47 Salix Pharmaceuticals $S
Post# of 37
Posted On: 11/07/2014 11:03:41 PM
Volume Alert - SLXP 91.47 Salix Pharmaceuticals $SLXP Hit a high today of 96.00 Closing the day 11/07/14 at 91.47 -47.08 -33.98% With a day low of 86.00 and a total volume of 25,989,627.
SLXP Recent Posts: http://investorshangout.com/Salix-Pharmaceuti...LXP-55453/
SLXP Salix Pharmaceuticals Recent Headline News
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - 1 hr 3 mins ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"
, announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP).
SLXP: 91.47 (-47.08)
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - 2 hrs 53 mins ago
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company" (NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders.
SLXP: 91.47 (-47.08)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.43 (-0.17), LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), AFSI: 49.89 (-0.58), EXPE: 85.11 (+1.05), FFIV: 126.66 (+1.45), SLXP: 91.47 (-47.08), MPWR: 44.69 (-0.13), TMH: 54.14 (-2.70), ATHM: 43.63 (-1.60)
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.24 (-0.12), PRSC: 38.48 (-0.90), FNGN: 31.39 (-9.43), LACO: 6.91 (-1.23), MSON: 11.80 (-2.44), SLXP: 91.47 (-47.08), FNHC: 26.14 (+0.04), MDRX: 11.54 (-2.01), PCMI: 7.45 (-3.15), UBNT: 28.78 (-5.84), PFMT: 7.04 (-1.61), ICPT: 172.59 (-74.39), ANDE: 54.79 (+2.83), ACTA: 16.52 (+0.62)
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix" for possible violations of federal securities laws.
SLXP: 91.47 (-47.08)
Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)
Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 91.47 (-47.08)
Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FSLR: 50.29 (-6.12), RIG: 29.71 (-0.21), WWWW: 15.40 (+0.68), GNRC: 40.86 (-1.23), SLXP: 91.47 (-47.08), BRKR: 17.91 (-2.98), KATE: 30.37 (-0.59), GNW: 8.41 (-0.25), SHLD: 42.81 (+10.14), ANR: 2.91 (+0.39), MCO: 98.95 (-0.04), HUM: 130.58 (-9.29)
Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 108.39 (+7.91), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00)
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), AKS: 6.62 (+0.48), SHLD: 42.81 (+10.14), VSAT: 65.39 (+5.13)
Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 91.47 (-47.08)
SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Fri Nov 07, 2:32PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (NASDAQ:SLXP). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Salix concerning the Company's financial results, operations and business prospects. Salix is engaged in the acquisition, development and commercialization of prescription drugs and medical devices in the United States to treat gastrointestinal diseases.
SLXP: 91.47 (-47.08)
Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour
at The Street - Fri Nov 07, 2:19PM CST
U.S. stocks slip on Friday afternoon, though with only slight moves, as Wall Street overlooks a mixed October jobs report to digest the big picture of a tightening labor market.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP
Business Wire - Fri Nov 07, 2:10PM CST
The Rosen Law Firm announces that it is investigating potential securities claims against Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) resulting from allegations that the Company may have issued materially misleading business information to the investing public.
SLXP: 91.47 (-47.08)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd.
Business Wire - Fri Nov 07, 1:02PM CST
Levi & Korsinsky, LLP is investigating Salix Pharmaceuticals, Ltd. ("Salix" or the "Company" (Nasdaq:SLXP) in connection with possible violations of federal securities laws by the Board of Directors of the Company.
SLXP: 91.47 (-47.08)
Most active Nasdaq-traded stocks
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
WFM: 46.81 (+1.96), FB: 75.60 (+0.34), SLXP: 91.47 (-47.08), ZNGA: 2.43 (+0.07), MSFT: 48.68 (-0.02), INTC: 33.58 (-0.24), AAPL: 109.01 (+0.31), CSCO: 25.33 (+0.07)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 12:01PM CST
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Salix Pharmaceuticals, Ltd. ("Salix Pharmaceuticals" or the "Company" (NasdaqGS: SLXP -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484.
SLXP: 91.47 (-47.08)
Salix Pharmaceuticals (SLXP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Nov 07, 10:30AM CST
The following Salix Pharmaceuticals (SLXP) conference call took place on November 6, 2014, 04:30 PM ET. This is a transcript of that earnings call:
SLXP: 91.47 (-47.08)
SLXP Recent Posts: http://investorshangout.com/Salix-Pharmaceuti...LXP-55453/
SLXP Salix Pharmaceuticals Recent Headline News
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO
Business Wire - 1 hr 3 mins ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"
, announces that KSF has commenced an investigation into Salix Pharmaceuticals Ltd. (Nasdaq: SLXP). SLXP: 91.47 (-47.08)
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - 2 hrs 53 mins ago
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Salix Pharmaceuticals Ltd. ("Salix" or the "Company"
(NASDAQ: SLXP), concerning whether the board has breached its fiduciary duties to shareholders. SLXP: 91.47 (-47.08)
Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.43 (-0.17), LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), AFSI: 49.89 (-0.58), EXPE: 85.11 (+1.05), FFIV: 126.66 (+1.45), SLXP: 91.47 (-47.08), MPWR: 44.69 (-0.13), TMH: 54.14 (-2.70), ATHM: 43.63 (-1.60)
Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.24 (-0.12), PRSC: 38.48 (-0.90), FNGN: 31.39 (-9.43), LACO: 6.91 (-1.23), MSON: 11.80 (-2.44), SLXP: 91.47 (-47.08), FNHC: 26.14 (+0.04), MDRX: 11.54 (-2.01), PCMI: 7.45 (-3.15), UBNT: 28.78 (-5.84), PFMT: 7.04 (-1.61), ICPT: 172.59 (-74.39), ANDE: 54.79 (+2.83), ACTA: 16.52 (+0.62)
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws
Business Wire - Fri Nov 07, 4:23PM CST
The law firm of Federman & Sherwood has launched an investigation into Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix"
for possible violations of federal securities laws. SLXP: 91.47 (-47.08)
Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)
Stock Movers: Why These 4 Medical Stocks Dived Today
at Investor's Business Daily - Fri Nov 07, 3:36PM CST
Raised eyebrows can lead to declining stock prices. Stocks On The Move down today include Salix Pharmaceuticals (SLXP), embroiled in drama as questions of accuracy and honesty cloud the drugmaker's weak Q3 results. Are its inventories accurate, and...
AGN: 196.00 (-1.40), VRX: 126.11 (-2.66), DVA: 74.49 (-3.54), GILD: 106.45 (-0.49), SLXP: 91.47 (-47.08), ICPT: 172.59 (-74.39), HUM: 130.58 (-9.29)
Look for Shares of Salix Pharmaceuticals to Potentially Rebound after Yesterday's 33.98% Sell Off
Comtex SmarTrend(R) - Fri Nov 07, 3:35PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $86.00 to a high of $96.00. Yesterday, the shares fell 34.0%, which took the trading range below the 3-day low of $134.40 on volume of 25.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 91.47 (-47.08)
Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FSLR: 50.29 (-6.12), RIG: 29.71 (-0.21), WWWW: 15.40 (+0.68), GNRC: 40.86 (-1.23), SLXP: 91.47 (-47.08), BRKR: 17.91 (-2.98), KATE: 30.37 (-0.59), GNW: 8.41 (-0.25), SHLD: 42.81 (+10.14), ANR: 2.91 (+0.39), MCO: 98.95 (-0.04), HUM: 130.58 (-9.29)
Dow, S&P 500 Flirt With Record, But Finish Just Off
at Investor's Business Daily - Fri Nov 07, 3:28PM CST
Stocks finished narrowly mixed Friday after the Dow Jones industrial average and the S&P 500 hit record intraday highs, then drifted off in the final hours of trading. The Nasdaq finished down 0.2%, the Dow climbed 0.1% and the S&P 500 was...
MNST: 108.39 (+7.91), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00)
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), AKS: 6.62 (+0.48), SHLD: 42.81 (+10.14), VSAT: 65.39 (+5.13)
Why Salix Pharmaceuticals Ltd. Stock Was Throttled
Sean Williams, The Motley Fool - Motley Fool - Fri Nov 07, 2:45PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Salix Pharmaceuticals , a biopharmaceutical company...
SLXP: 91.47 (-47.08)
SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Fri Nov 07, 2:32PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company"
(NASDAQ:SLXP). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Salix concerning the Company's financial results, operations and business prospects. Salix is engaged in the acquisition, development and commercialization of prescription drugs and medical devices in the United States to treat gastrointestinal diseases. SLXP: 91.47 (-47.08)
Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour
at The Street - Fri Nov 07, 2:19PM CST
U.S. stocks slip on Friday afternoon, though with only slight moves, as Wall Street overlooks a mixed October jobs report to digest the big picture of a tightening labor market.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP
Business Wire - Fri Nov 07, 2:10PM CST
The Rosen Law Firm announces that it is investigating potential securities claims against Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) resulting from allegations that the Company may have issued materially misleading business information to the investing public.
SLXP: 91.47 (-47.08)
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd.
Business Wire - Fri Nov 07, 1:02PM CST
Levi & Korsinsky, LLP is investigating Salix Pharmaceuticals, Ltd. ("Salix" or the "Company"
(Nasdaq:SLXP) in connection with possible violations of federal securities laws by the Board of Directors of the Company. SLXP: 91.47 (-47.08)
Most active Nasdaq-traded stocks
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
WFM: 46.81 (+1.96), FB: 75.60 (+0.34), SLXP: 91.47 (-47.08), ZNGA: 2.43 (+0.07), MSFT: 48.68 (-0.02), INTC: 33.58 (-0.24), AAPL: 109.01 (+0.31), CSCO: 25.33 (+0.07)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Salix Pharmaceuticals Ltd.
PR Newswire - Fri Nov 07, 12:01PM CST
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Salix Pharmaceuticals, Ltd. ("Salix Pharmaceuticals" or the "Company"
(NasdaqGS: SLXP -News). Such investors are advised to contact Peretz Bronstein or his investor relations coordinator Eitan Kimelman at info@bgandg.com or 212-697-6484. SLXP: 91.47 (-47.08)
Salix Pharmaceuticals (SLXP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Nov 07, 10:30AM CST
The following Salix Pharmaceuticals (SLXP) conference call took place on November 6, 2014, 04:30 PM ET. This is a transcript of that earnings call:
SLXP: 91.47 (-47.08)
(0)
(0)Salix Pharmaceuticals Ltd. (SLXP) Stock Research Links
Scroll down for more posts ▼